SCHEMBL5686010

SCHEMBL5686010

Cc1[nH]c2ccccc2c1C1=C(c2c(CCCC(N)=O)[nH]c3ccccc23)C(=O)NC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 2/20 0.50
PRKCB P05771 1/20 0.42
PRKCA P17252 1/20 0.42
PRKCH P24723 1/20 0.42
PRKCE Q02156 1/20 0.42
PRKCQ Q04759 1/20 0.42
PRKCD Q05655 1/20 0.42
EGFR P00533 3/20 0.41
SRC P12931 2/20 0.41
GSK3B P49841 1/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.39
CCR6 P51684 1/20 0.38
HKDC1 Q2TB90 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
MAP2 P11137 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7785201 0.87 CAMK2D (0.61) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL5683201 0.83 CAMK2D (0.50) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL7782574 0.82 CAMK2D (0.48) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL5686050 0.80 CAMK2D (0.57) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL5792870 0.78 KDM4E (0.44) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL5683170 0.78 CAMK2D (0.52) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL6865510 0.78 CDK4 (0.41) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL5683260 0.77 MEN1 (0.51) CAMK2DGSK3BKDM4EPOLBALDH1A1
SCHEMBL6867156 0.77 CDK4 (0.40) CAMK2DPRKCBPRKCAPRKCHPRKCE
SCHEMBL6867375 0.77 CDK4 (0.40) CAMK2DPRKCBPRKCAPRKCHPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005028678-A9 METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY WYETH CORP (US) 2006-08-31 WO disclosed
EP-1636388-A2 METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY Wyeth (US) 2006-03-22 EP disclosed
WO-2005028678-A2 METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY WYETH (US) 2005-03-31 WO disclosed
EP-1140070-A1 TREATMENT OF CONDITIONS WITH A NEED FOR THE INHIBITION OF GSK-3 SMITHKLINE BEECHAM PLC (GB) 2001-10-10 EP disclosed
WO-2000038675-A1 TREATMENT OF CONDITIONS WITH A NEED FOR THE INHIBITION OF GSK-3 SMITHKLINE BEECHAM PLC (GB) 2000-07-06 WO disclosed